MACQUARIE GROUP LTD 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:34 pm Sale |
2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
MACQUARIE GROUP LTD | 1,323,547 2.340% |
-1,589,924 (-54.57%) |
Filing |
| 2022-02-14 11:15 am Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
MACQUARIE GROUP LTD | 2,913,471 5.230% |
-278,563 (-8.73%) |
Filing |
| 2021-02-12 08:25 am Purchase |
2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
MACQUARIE GROUP LTD | 3,192,034 5.830% |
94,212 (+3.04%) |
Filing |